Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-06-21, Stock:JNJ, The news for the past five days is as follows:
2021-06-14: NEWS1: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS2: Novavax CEO: Its COVID-19 vaccine will have biggest impact outside of US.NEWS3: Brazil extends validity of J&J COVID vaccine to 4.5 months.NEWS4: Is Johnson & Johnson (JNJ) A Good Stock To Buy?.NEWS5: We’re a good 18 months away before there’s enough vaccine to stop COVID-19’s worldwide spread: Epidemiologist.NEWS6: Most of our vaccine will go to middle and low income countries: Novavax CEO.NEWS7: Ethics have been ‘pushed to the back’ amid COVID-19: Doctor.NEWS8: 10 Best High Yield Dividend Stocks to Buy in June.NEWS9: J&J (JNJ) Gets FDA Nod for 10M COVID Vaccines, Discards Many.NEWS10: UPDATE 2-J&J to send S.Africa more than 300,000 vaccine doses, says Aspen.NEWS11: Moderna hires J&J executive as chief medical officer.NEWS12: Johnson & Johnson Building Case With New Patient Survival Data For Darzalex In Multiple Myeloma.NEWS13: JNJ's Imbruvica, AbbVie's Venclexta Combo Achieves Progression-Free Survival Of 78.4% Versus Gazyva-Chemo Cocktail In Leukemia Patients.NEWS14: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.NEWS15: This Is Hands Down the Safest Robinhood Stock You Can Buy Right Now.NEWS16: Novavax Soars As Its COVID-19 Vaccine Is Found 90% Effective, To Seek FDA OK.
2021-06-15: NEWS1: UPDATE 2-U.S. authorizes another 14 mln doses of Johnson & Johnson's COVID-19 vaccine -sources.NEWS2: Workers sue over mandatory COVID-19 vaccination.NEWS3: UPDATE 1-J&J to send 2 million COVID-19 vaccine doses to S.Africa by end-June -President Ramaphosa.NEWS4: Novavax's (NVAX) COVID-19 Vaccine Shows 90% Efficacy in US Study.NEWS5: This Biotech Stock Has Big Potential.NEWS6: Should Oshares U.S. Quality Dividend ETF (OUSA) Be on Your Investing Radar?.NEWS7: Argenx Is a Biotech Stock With Big Potential.NEWS8: The Johnson & Johnson Charts Are Healthy Enough for Further Gains.NEWS9: AstraZeneca's 'Storm Chaser' COVID trial misses goal but offers some hope.NEWS10: UPDATE 1-Malaysia grants conditional approval for CanSino, J&J COVID-19 vaccines.
2021-06-16: NEWS1: Here's Why Orphazyme Shares Rocketed Higher on Wednesday.NEWS2: COVID-19 pandemic is ‘far from over in other parts of the world’: Doctor.NEWS3: JNJ Unlikely To Meet Q2 COVID-19 Vaccine Supply Target To EU: Reuters.NEWS4: FDA ‘shifting the bar’ for approval with new Alzheimer’s drug: Eli Lilly CEO.NEWS5: Coronavirus vaccine: 'We don’t even realize how lucky we are' in America.NEWS6: UPDATE 5-EU says J&J to miss vaccine supply target in second quarter.NEWS7: Moderna Just Eliminated This 1 Risk.NEWS8: EU says J&J to miss vaccine supply target in second quarter.
2021-06-17: NEWS1: The latest on the Covid-19 pandemic in the U.S..NEWS2: 10 Best Healthcare Stocks to Buy According to Hedge Funds.NEWS3: Affordable Care Act survives third Supreme Court challenge.NEWS4: Mayo Clinic, nference AI Analysis Find No Real-World Link Between COVID-19 Shots And Clots.NEWS5: Supreme Court upholds Obamacare in latest ruling.NEWS6: EU drug regulator records 415 cases of possible rare blood clotting.NEWS7: By next summer we'll have enough vaccines to vaccinate the world: Eli Lilly CEO.NEWS8: Influencers with Andy Serwer: David Ricks.
2021-06-18: NEWS1: Gov. Ducey’s decision to block COVID-19 policies for universities is ‘not based in science’: Doctor.NEWS2: German lab, J&J still hashing out details of COVID-19 vaccine clot collaboration.

Answer: Rise